These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38445155)

  • 21. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
    Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
    Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of statins in primary prevention.
    Rosian I; Pichlbauer E; Stürzlinger H
    GMS Health Technol Assess; 2006 Apr; 2():Doc10. PubMed ID: 21289961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Arterial Axis Lesions in Proximal Humeral Fractures-Case Report and Literature Review.
    Faur CI; Nitu R; Abu-Awwad SA; Tudoran C; Abu-Awwad A
    J Pers Med; 2023 Dec; 13(12):. PubMed ID: 38138939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of statin therapy for stroke prevention.
    Sett AK; Robinson TG; Mistri AK
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1305-14. PubMed ID: 21985543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer.
    Morofuji Y; Nakagawa S; Ujifuku K; Fujimoto T; Otsuka K; Niwa M; Tsutsumi K
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.
    Izquierdo-Palomares JM; Fernandez-Tabera JM; Plana MN; Añino Alba A; Gómez Álvarez P; Fernandez-Esteban I; Saiz LC; Martin-Carrillo P; Pinar López Ó
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009462. PubMed ID: 27888640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
    JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mechanistic and clinical implications concerning the safety of statin discontinuation.
    Jasińska-Stroschein M; Owczarek J; Wejman I; Orszulak-Michalak D
    Pharmacol Rep; 2011; 63(4):867-79. PubMed ID: 22001974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of statin pleiotropism in acute coronary syndromes and stroke.
    Liao JK
    Int J Clin Pract Suppl; 2003 Mar; (134):51-7. PubMed ID: 12793598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors.
    Mohamad T; Jyotsna F; Farooq U; Fatima A; Kar I; Khuwaja S; Memon UA; Kumari V; Puri P; Aslam ZM; Elder Z; Varrassi G; Paladini A; Khatri M; Kumar S; Muzammil MA
    Cureus; 2023 Aug; 15(8):e43977. PubMed ID: 37746355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins and stroke prevention.
    Amarenco P; Lavallée P; Touboul PJ
    Cerebrovasc Dis; 2004; 17 Suppl 1():81-8. PubMed ID: 14694285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalizing cholesterol treatment recommendations for primary cardiovascular disease prevention.
    Sarraju A; Ward A; Li J; Valencia A; Palaniappan L; Scheinker D; Rodriguez F
    Sci Rep; 2022 Jan; 12(1):23. PubMed ID: 34996943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial.
    Byrne JL; Dallosso HM; Rogers S; Gray LJ; Waheed G; Patel P; Gupta P; Doherty Y; Davies MJ; Khunti K
    BMC Med; 2020 Jul; 18(1):198. PubMed ID: 32713349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Menstrual Cycle's Influence on Sleep Duration and Cardiovascular Health: A Comprehensive Review.
    Rugvedh P; Gundreddy P; Wandile B
    Cureus; 2023 Oct; 15(10):e47292. PubMed ID: 38022155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond lipid lowering: the role of statins in vascular protection.
    Liao JK
    Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System.
    Lucas JE; Bazemore TC; Alo C; Monahan PB; Voora D
    PLoS One; 2017; 12(11):e0187809. PubMed ID: 29155848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins in stroke prevention: what an internist should know.
    Castilla Guerra L; del Carmen Fernández Moreno M; López Chozas JM; Jiménez Hernández MD
    Eur J Intern Med; 2008 Jan; 19(1):8-14. PubMed ID: 18206595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.